Liquidia Corporation

NasdaqCM:LQDA

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

💊 Drugstores & Retail Pharmacies

💊 Pharmaceuticals

Location

United States

Market Cap

USD 1.21 B

Share Price

USD 14.09

Avg Daily Volume

1,539,774

Change (1 day)

-0.07%

Change (1 year)

8.89%

Change (YTD)

19.81%

Liquidia Corporation Price to Book Ratio (P/B) on June 16, 2025: 16.06

Liquidia Corporation Price to Book Ratio (P/B) is 16.06 on June 16, 2025, a -177.79% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Liquidia Corporation 52-week low Price to Book Ratio (P/B) is 22.00 on June 16, 2025, which is 36.98% above the current Price to Book Ratio (P/B).
Liquidia Corporation 52-week low Price to Book Ratio (P/B) is -20.10 on June 16, 2025, which is -225.17% below the current Price to Book Ratio (P/B).
Liquidia Corporation average Price to Book Ratio (P/B) for the last 52 weeks is 13.53.

Daily

From:

To:

Zoom:

3M
6M
YTD
1Y
3Y
5Y
10Y
15Y
20Y
Max

Key data

Date	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)	Enterprise Value to EBITDA (EV/EBITDA)	Free Cash Flow Yield

NasdaqCM: LQDA

Liquidia Corporation

CEO	Dr. Roger A. Jeffs Ph.D.
IPO Date	July 26, 2018
Location	United States
Headquarters	419 Davis Drive
Employees	170
Sector	🏥 Health Care
Industries Clinical Trials 🧬 Biotechnology 💊 Drugstores & Retail Pharmacies 💊 Pharmaceuticals

Description

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Similar companies

Eli Lilly and Company

USD 807.58

-1.44%

AbbVie Inc.

USD 190.86

-0.11%

Roche Holding AG

USD 343.54

-2.65%

AstraZeneca PLC

USD 146.80

-1.46%

Merck & Co., Inc.

USD 80.96

-0.92%

Amgen Inc.

USD 295.56

0.11%

Pfizer Inc.

USD 24.40

-0.57%

Gilead Sciences, Inc.

USD 110.83

0.77%

Sanofi

USD 99.27

-0.99%

Bristol-Myers Squibb Company

USD 48.66

-2.19%

Chugai Pharmaceutical Co., Ltd.

USD 50.88

-1.30%

GSK plc

USD 20.16

-1.65%

Cencora, Inc.

USD 292.50

-1.03%

Regeneron Pharmaceuticals, Inc.

USD 522.68

-1.24%

Haleon plc

USD 5.31

-1.21%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.49

-0.21%

Takeda Pharmaceutical Company Limited

USD 30.06

0.34%

Daiichi Sankyo Company, Limited

USD 23.88

-1.07%

UCB SA

USD 187.20

-0.85%

Hansoh Pharmaceutical Group Company Limited

USD 3.66

-1.84%

Teva Pharmaceutical Industries Limited

USD 17.50

1.85%

Insmed Incorporated

USD 101.59

2.90%

West Pharmaceutical Services, Inc.

USD 224.30

1.08%

Summit Therapeutics Inc.

USD 19.95

0.86%

Cipla Limited

USD 17.68

-0.41%

Dr. Reddy's Laboratories Limited

USD 15.64

-0.12%

United Therapeutics Corporation

USD 288.56

1.84%

Torrent Pharmaceuticals Limited

USD 38.31

0.59%

CSPC Pharmaceutical Group Limited

USD 1.06

-4.53%

Sino Biopharmaceutical Limited

USD 0.65

-3.37%

Mankind Pharma Limited

USD 27.51

-0.17%

Zydus Lifesciences Limited

USD 11.28

-0.45%

BioMarin Pharmaceutical Inc.

USD 56.24

0.04%

Ascendis Pharma A/S

USD 177.71

4.05%

Viatris Inc.

USD 8.99

0.78%

Lupin Limited

USD 23.21

-0.72%

Swedish Orphan Biovitrum AB (publ)

USD 30.30

1.17%

Huadong Medicine Co., Ltd

USD 6.08

-1.93%

Orion Oyj

USD 73.11

-0.01%

Ipsen S.A.

USD 119.99

0.56%

Kyowa Kirin Co., Ltd.

USD 17.16

-0.50%

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

USD 2.09

-1.87%

Shanghai Pharmaceuticals Holding Co., Ltd

USD 1.52

1.05%

Sichuan Kelun Pharmaceutical Co., Ltd.

USD 5.01

-2.15%

Abbott India Limited

USD 367.89

-0.11%

Eisai Co., Ltd.

USD 27.67

-0.60%

Shenzhen Salubris Pharmaceuticals Co., Ltd.

USD 7.50

-1.99%

Sinopharm Group Co. Ltd.

USD 2.35

-0.07%

Beijing Tongrentang Co., Ltd

USD 5.06

-0.92%

Haisco Pharmaceutical Group Co., Ltd.

USD 6.30

-2.53%

StockViz Staff

June 17, 2025

Any question? Send us an email